Alpha Teknova Inc
NASDAQ:TKNO
Intrinsic Value
Alpha Teknova, Inc. manufactures cell culture media and supplements. [ Read More ]
The intrinsic value of one TKNO stock under the Base Case scenario is 5.78 USD. Compared to the current market price of 1.7 USD, Alpha Teknova Inc is Undervalued by 71%.
Valuation Backtest
Alpha Teknova Inc
Run backtest to discover the historical profit from buying and selling TKNO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Alpha Teknova Inc
Current Assets | 45.7m |
Cash & Short-Term Investments | 28.6m |
Receivables | 3.9m |
Other Current Assets | 13.1m |
Non-Current Assets | 82.9m |
PP&E | 66.8m |
Intangibles | 14.2m |
Other Non-Current Assets | 1.9m |
Current Liabilities | 8.9m |
Accounts Payable | 1.5m |
Accrued Liabilities | 6.3m |
Other Current Liabilities | 1m |
Non-Current Liabilities | 29.7m |
Long-Term Debt | 13.3m |
Other Non-Current Liabilities | 16.4m |
Earnings Waterfall
Alpha Teknova Inc
Revenue
|
36.7m
USD
|
Cost of Revenue
|
-26.4m
USD
|
Gross Profit
|
10.3m
USD
|
Operating Expenses
|
-41.5m
USD
|
Operating Income
|
-31.2m
USD
|
Other Expenses
|
-5.6m
USD
|
Net Income
|
-36.8m
USD
|
Free Cash Flow Analysis
Alpha Teknova Inc
TKNO Profitability Score
Profitability Due Diligence
Alpha Teknova Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Alpha Teknova Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
TKNO Solvency Score
Solvency Due Diligence
Alpha Teknova Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Alpha Teknova Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TKNO Price Targets Summary
Alpha Teknova Inc
According to Wall Street analysts, the average 1-year price target for TKNO is 5.61 USD with a low forecast of 5.05 USD and a high forecast of 6.3 USD.
Ownership
TKNO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
TKNO Price
Alpha Teknova Inc
Average Annual Return | -43.74% |
Standard Deviation of Annual Returns | 42.84% |
Max Drawdown | -94% |
Market Capitalization | 69.3m USD |
Shares Outstanding | 40 793 800 |
Percentage of Shares Shorted | 0.46% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Alpha Teknova, Inc. manufactures cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 231 full-time employees. The company went IPO on 2021-06-25. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Its processes enable it to manufacture and deliver custom, made-to-order products across all stages of development, including commercialization. The firm's processes are designed to handle as array of customer-requested inputs, which vary by volume, chemical formulation, quality specifications, container types, and transportation requirements, enabling use of its products across the scope of the life sciences market.
Contact
IPO
Employees
Officers
The intrinsic value of one TKNO stock under the Base Case scenario is 5.78 USD.
Compared to the current market price of 1.7 USD, Alpha Teknova Inc is Undervalued by 71%.